Comments

Xenetic Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Xenetic Biosciences (XBIO) operate in?

Xenetic Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

XBIONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$3.01

-0.23-7.01%

At close: -

$2.99

-0.02-0.76%

After Hours: Jun 2, 7:00 AM EDT

Xenetic Biosciences (XBIO) Forecast

News Earnings Xenetic Biosciences (XBIO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Xenetic Biosciences Stock Price, Quotes and Forecasts | NASDAQ:XBIO | Benzinga

Explore Xenetic Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XBIO.

Open	$3.01
Close	$3.01
Volume / Avg.	7.84K / 8.33K
Day Range	$3.00 - $3.22
52 Wk Range	2.20 - 5.20
Market Cap	$4.61M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	0.24%
Days to Cover	1

Recent News

Xenetic Biosciences Reports Q1 Loss, Misses Revenue Estimates

Xenetic Biosciences (NASDAQ: XBIO) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $0.60 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Lack Of Catalysts Prompts Analyst To Downgrade Xenetic Biosciences

Vandana Singh

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

Buy

Hold

Sell

Strong Sell

Open	$3.01
Close	$3.01
Volume / Avg.	7.84K / 8.33K
Day Range	$3.00 - $3.22
52 Wk Range	2.20 - 5.20
Market Cap	$4.61M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	0.24%
Days to Cover	1

About Xenetic Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncolo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Xenetic Biosciences (XBIO) stock?

You can purchase shares of Xenetic Biosciences (NASDAQ:XBIO) through any online brokerage.

View our list of the best stock brokerages

Who are Xenetic Biosciences (XBIO) competitors?

Other companies in Xenetic Biosciences’s space includes: Galecto (NASDAQ:GLTO), Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX) and Quoin Pharmaceuticals (NASDAQ:QNRX).

What is the forecast, or price target, for Xenetic Biosciences (XBIO) stock?

There is no analysis for Xenetic Biosciences to provide a consensus price target.

What is the current price for Xenetic Biosciences (XBIO)?

The stock price for Xenetic Biosciences (NASDAQ: XBIO) is $2.99 last updated June 2, 2025 at 7:00 AM EDT.

Does Xenetic Biosciences (XBIO) pay a dividend?

There are no upcoming dividends for Xenetic Biosciences.

When is Xenetic Biosciences (NASDAQ:XBIO) reporting earnings?

Xenetic Biosciences’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is Xenetic Biosciences (XBIO) going to split?

There is no upcoming split for Xenetic Biosciences.

What sector and industry does Xenetic Biosciences (XBIO) operate in?

Xenetic Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.